Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2003Leukemia & lymphoma/Leukemia and lymphoma

Current Status and Future of Relapsed Primary Central Nervous System Lymphoma (PCNSL)

View Full Paper
Ask AI
Bookmark
Share

Authors

RTRose Marie TysonOregon Health & Science UniversityTSTali SiegalTel Aviv UniversityNDNancy D. DoolittleOregon Health & Science University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tyson et al. (2003) studied this question.

synapsesocial.com/papers/6a9eed56fb077ebd42be363fhttps://doi.org/10.1080/1042819021000055057
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?1997 · 176 citations
  2. 2Treatment for Primary CNS Lymphoma: The Next Step2000 · 612 citations
  3. 3Toxicity and Efficacy of Carboplatin and Etoposide in Conjunction with Disruption of the Blood-Brain Tumor Barrier in the Treatment of Intracranial Neoplasms1995 · 109 citations
  4. 4Cognitive Outcomes and Long-term Follow-up Results after Enhanced Chemotherapy Delivery for Primary Central Nervous System Lymphoma2000 · 227 citations
  5. 5Pilot Study of the Combination of Melphalan, Carboplatin and Etoposide as a Conditioning Regimen for Relapsed Lymphoma Patients1999 · 5 citations